SeoulCeuticals Publishes First Official Layering Guide for Volufiline Snail Mucin Serum, Identifying Retinol Sequencing as the Cause of Preventable Irritation for Millions of Users
Verum Messenger Introduces Major Platform Update Expanding Privacy, Connectivity, and Digital Ecosystem
Studio 6 Grows Extended Stay Footprint with 35+ New Locations in 2026
Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations
OSS Plans to Showcase Specialized High-Performance AI Computing Solutions at The Navy League’s Sea-Air-Space Exposition on April 19-22
REDUCE-IT® patients experienced substantial cardiovascular (CV) risk reduction with icosapent ethyl regardless of the presence…
– Reported 50% response rate in visual sensitivity among patients in highest dose groups in…
– ANX005 Huntington’s Disease Phase 2 trial fully enrolled with data anticipated 2H 2021 –…
COPENHAGEN, Denmark, May 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
BURLINGAME, Calif., May 17, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq:…
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has…
– Recent New Drug Application Resubmission for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) – –…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
KIN-2787 is the company’s RAF inhibitor candidate for patients with mutant BRAF-driven solid tumors Planned…
FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to…
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., May 17, 2021…
The National Institute of Allergy and Infectious Diseases will fund the continued clinical development of…
CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
NEWTON, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Advancing two lead product candidates in Phase 1/2 clinical trials Completed successful $126M initial public…
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase…
Advicenne reçoit un avis positif de la FDA sur la procédure d’approbation et l’Agence accepte…